Donna McMorrow has extensive experience designing observational studies and retrospective database analyses using a range of data sources, including administrative claims and electronic health records.
Donna has co-authored numerous conference abstracts and more than 30 manuscripts published in peer-reviewed journals across a wide range of therapeutic areas, including oncology, rheumatology, asthma, COPD, and endocrinology.
With more than 15 years of experience in health outcomes and health services research, Donna previously served as a Principal Research Analyst at Merative, formerly IBM Watson Health, where she supported real-world retrospective studies for life sciences partners. Earlier in her career, she conducted complex pharmacy analytics as a Senior Pharmacy Finance Consultant at a large regional health plan.
Donna holds a Bachelor of Science in Business Administration.
Flare Frequency, Organ Damage, and Economic Burden Among Individuals With Immunoglobulin G4-Related Disease (IgG4-RD) in the United States
Accepted for presentation at International Society for Pharmacoeconomics and Outcomes Research. Findings available upon request. Contact us for more information.
Real-World Effectiveness of Budesonide/Glycopyrrolate/Formoterol Fumarate on COPD Exacerbations and Healthcare Costs by Eosinophil Level: Results From the U.S. ARCTOS Study
Accepted for presentation at American Thoracic Society International Conference. Findings available upon request. Contact us for more information.
Reduction in COPD Exacerbations Following Prompt Triple Therapy Initiation After Hospital Discharge: Results from the MITOS EROS Discharge Study (U.S.)
Accepted for presentation at American Thoracic Society International Conference. Findings available upon request. Contact us for more information.
Lipoprotein(a) Impact on Atherosclerotic Cardiovascular Disease and Major Adverse Limb Events Among Patients With Peripheral Artery Disease
Accepted for presentation at American College of Cardiology. Findings available upon request. Contact us for more information.
Impact of Elevated Lipoprotein(a) on Cardiovascular Events in Patients With Premature ASCVD: A Nationally Representative Sample of U.S. Medicare, Medicaid, and Commercial Enrollees
Accepted for presentation at American Heart Association. Findings available upon request. Contact us for more information.